Oxidized lipoproteins, altered cell function and atherosclerosis

Atherosclerosis

Volumn 108, Issue SUPPL., 1994, Pages

  Penn, Marc S ^a   Chisolm, Guy M ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Antioxidants; Atherosclerosis; Cell injury; Cell motility; Oxidized LDL

Indexed keywords

ALPHA TOCOPHEROL; ANTIOXIDANT; BUTYLCRESOL; CHELATING AGENT; LOW DENSITY LIPOPROTEIN; PROBUCOL; PROTECTIVE AGENT;

ATHEROGENESIS; ATHEROSCLEROSIS; CELL DAMAGE; CELL MOTILITY; CONFERENCE PAPER; HUMAN; LIPOPROTEIN METABOLISM; OXIDATION; PREVENTION; PRIORITY JOURNAL;

ANIMAL; ARTERIOSCLEROSIS; BLOOD VESSELS; CELL MOVEMENT; CELLS, CULTURED; HUMAN; LIPOPROTEINS, LDL; MACROPHAGES; OXIDATION-REDUCTION;

EID: 0028022781     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/0021-9150(94)90150-3     Document Type: Article

References (83)

1. Modification of human serum low density lipoprotein by oxidation — characterization and patho-physiologic implications
2. Beyond cholesterol. Modifications of low-density lipoprotein that increase its athero-genicity
3. Role of oxidatively modified LDL in atherosclerosis
4. The oxidation of lipoproteins: implications for atherosclerosis
5. Enhanced macrophage degradation of low density lipoprotein previously incubated with cultured endothelial cells: recognition by receptors for acetylated low density lipoproteins
6. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids
7. LDL-induced cytotoxicity and its inhibition by HDL in human vascular smooth muscle and endothelial cells in culture
8. Injury to human endothelial cells in culture induced by low density lipoproteins
9. Lipoprotein oxidation and lipoprotein-induced cytotoxicity
10. Low density lipoprotein cytotoxicity induced by free radical peroxidation of lipid
11. Low density lipoprotein undergoes oxidative modification in vivo
12. Malondialdehyde-altered protein occurs in atheroma of Watanabe heritable hyperlipidemic rabbits
13. Direct evidence for a protein recognized by a monoclonal antibody against oxidatively modified LDL in atherosclerotic lesions from a Watanabe heritable hyperlipidemic rabbit
14. Monoclonal DLR1a/104G antibody recognizing peroxidized lipoproteins in atherosclerotic lesions
15. Evidence for the presence of oxidatively modified low density lipoprotein in atherosclerotic lesions of rabbit and man
16. Probucol prevents the progression of atherosclerosis in Watanabe heritable hyperlipidemic rabbit, an animal model for familial hypercholesterolemia
17. Antiatherogenic effect of probucol unrelated to its hypoc-holesterolemic effect: evidence that antioxidants in vivo can selectively inhibit low density lipoprotein degradation in macrophage-rich fatty streaks and slow the progression of atherosclerosis in the Watanabe heritable hyperlipidemic rabbit
18. Beta carotene therapy for chronic stable angina
19. Vitamin E consumption and the risk of coronary disease in women
20. Vitamin E consumption and the risk of coronary disease in men
21. The antioxidant butylated hydroxytoluene protects against atherosclerosis
22. Low density lipoprotein is protected from oxidation and the progression of atherosclerosis is slowed in cholesterol-fed rabbits by the antioxidant N,N′-diphenyl-phenyenediamine
23. Antioxidants and atherosclerosis: a current assessment
24. Effects of d-a-tocopherol supplementation on experimentally induced primate atherosclerosis
25. STUDIES ON THE ROLE OF LIPOPEROXIDES IN HUMAN PATHOLOGY
26. Macrophages and ceroid in human atherosclerosis
27. Distribution of oxidation specific lipid-protein adducts and apolipoprotein B in atherosclerotic lesions of varying severity from WHHL rabbits
28. Isolation of a low density lipoprotein from atherosclerotic vascular tissue of WHHL rabbits
29. Relationship between low density lipoprotein in aortic intima and serum lipid levels
30. Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein
31. Injury to cultured endothelial cells induced by low density lipoproteins: protection by high density lipoproteins
32. Oxidized low density lipoprotein can reduce the pinocytic activity in cultured human endothelial cells as measured by cellular uptake of sucrose
33. Ultraviolet-treated lipoproteins as a model system for the study of the biological effects of lipid peroxides on cultured cell. II. Uptake and cytotoxicity of ultraviolet-treated LDL on lymphoid cell lines
34. Expression of type I and type II bovine scavenger receptors in Chinese hamster ovary cells: lipid droplet accumulation and non-reciprocal cross competition by acetylated and oxidized low density lipoprotein
35. CD36 is a receptor for oxidized low density lipoprotein
36. A macrophage Fc receptor for IgG is also a receptor for oxidized low density lipoprotein
37. Lipo-protein mediated inhibition of endothelial cell production of platelet-derived growth factor-like proteins depends on free radical lipid peroxidation
38. Multiple receptors for modified low density lipoproteins in mouse peritoneal macrophages: different uptake mechanisms for acetylated and oxidized low density lipoproteins
39. A macrophage receptor that recognizes oxidized low density lipoprotein but not acetylated low density lipoprotein
40. Type I macrophage scavenger receptor contains a-helical and collagen-like coiled coils
41. Coiled-coil fibrous domains mediate binding by the macrophage scavenger type II
42. Interaction of low density lipoproteins with human aortic elastin
43. Effects of copper and histidine on oxidative modification of low density lipoprotein and its subsequent binding to collagen
44. Modification of copper-catalyzed oxidation of low density lipoprotein by proteoglycans and glycosaminoglycans
45. Effect of arterial proteoglycans and glycosaminoglycans on low density lipoprotein oxidation and its uptake by human macrophages and arterial smooth muscle cells
46. Endothelial and smooth muscle cells alter low density lipoprotein in vitro by free radical oxidation
47. Macrophage oxidation of low density lipoprotein generates a form recognized by the scavenger receptor
48. Oxidative modification of low density lipoprotein (LDL) by activated
49. Monocytes and neutrophils oxidize low density lipoprotein making it cytotoxic
50. Oxidized low density lipoprotein suppresses the expression of tumor necrosis factor-alpha mRNA in stimulated murine peritoneal macrophages
51. The influence of oxidatively modified low density lipoproteins on expression of platelet-derived growth factor by human monocyte-derived macrophages
52. Native and oxidized LDL enhances production of PDGF AA and the surface expression of PDGF receptors in cultured human smooth muscle cells
53. Induction of murine macrophage growth by modified LDLs
54. Role of oxidized human plasma low density lipoproteins in atherosclerosis: effects on smooth muscle cell proliferation
55. Induction of endothelial cell expression of granulocyte and macrophage colony-stimulating factors by modified low-density lipoproteins
56. Inhibition of lipopolysaccharide-induced interleukin-1 beta mRNA expression in mouse macrophages by oxidized low density lipoprotein
57. Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis
58. Endothelial cell-derived chemotactic activity for mouse peritoneal macrophages and the effects of modified forms of low density lipoprotein
59. Oxidized low-density lipoprotein is chemotactic for arterial smooth muscle cells in culture
60. Oxidized low density lipoprotein inhibits the migration of aortic endothelial cells in vitro
61. Lysophosphatidylcholine: a chemotactic factor for human monocytes and its potential role in atherogenesis
62. Analysis of the monocyte chemotactic response to lysophosphatidylcholine: role of lysophospholipase C
63. Minimally modified low density lipoprotein stimulates monocyte endothelial interactions
64. Minimally modified low density lipoprotein induces monocyte chemotactic protein 1 in human endothelial cells and smooth muscle cells
65. Expression of monocyte chemoattractant protein 1 in macrophage-rich areas of human and rabbit atherosclerotic lesions.
66. Oxidized low density lipoprotein induces differentiation and adhesion of human monocytes and the monocytic cell line U937
67. Receptors for modified low-density lipoproteins on human endothelial cells: different recognition for acetylated lowdensity lipoprotein and oxidized low-density lipoprotein
68. Role of leukotrienes in leukocyte adhesion following systemic administration of oxidatively modified human low density lipoprotein in hamsters
69. Oxidized lipoproteins and leukocyte-endothelial interactions: growing evidence for multiple mechanisms
70. Oxidized LDL-induced leukocyte/endothelium interaction in vivo involves the receptor for platelet-activating factor
71. Stimulation of leukocyte/endothelium interaction by oxidized lowdensity lipoprotein in hairless mice. Involvement of CD11b/CD18 adhesion receptor complex
72. Oxidized low-density lipoprotein enhances monocyte-endothelial cell binding against shear-stress-induced detachment
73. Cytotoxicity of oxidized lipoproteins
74. Inhibition of glutathione synthesis increases the toxicity of oxidized low-density lipoprotein to human monocytes and macrophages
75. Toxicity of oxidized low-density lipoprotein to cultured fibroblasts is selective for S phase of the cell cycle
76. Lethal damage to endothelial cells by oxidized low density lipoprotein: role of selenoperoxidases in cytoprotection against lipid hydroperoxide-and iron-mediated reactions
77. Lipoxygenase-mediated transformation of human low density lipoprotein to an oxidized and cytotoxic complex
78. Antioxidant treatment of diabetic rats inhibits lipoprotein oxidation and cytotoxicity
79. Oxidized HDL are much less cytotoxic to lymphoblastoid cells than oxidized LDL
80. Ultraviolet-treated lipoproteins as a model system for the study of the biological effects of lipid peroxides on cultured cells. III. The protective effect of antioxidants (probucol, catechin, vitamin E) against the cytotoxicity of oxidized LDL occurs in two different ways
81. Protective role of intracellular glutathione against oxidized low density lipoprotein in cultured endothelial cells
82. Involvement of intracellular iron in the toxicity of oxidized low density lipoprotein to cultured endothelial cells
83. Probucol prevents oxidative injury to endothelial cells